Heparin: all 148 studies that test it

Page 1 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.

• Heparin to Prevent Organ Failure in Acute PancreatitisNot yet recruitingNCT07609771Phase 4
• Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)RecruitingNCT06453876Phase 3
• Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket TrialRecruitingNCT06381661Phase 2
• Comparison Between Haparin and Herodin in HDNot yet recruitingNCT06112262Early Phase 1
• Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp SystemRecruitingNCT06080074Phase 2
• BivaLirudin versUS Heparin in Extracorporeal Membrane OxygenationRecruitingNCT05959252Phase 2
• AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired PneumoniaRecruitingNCT05848713Phase 3
• Effect of Different Heparinization Schemes on Prognosis of Intracranial AneurysmRecruitingNCT05749393Not applicable
• Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPSRecruitingNCT05737121Phase 2
• Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative HysteroscopyRecruitingNCT05257213Not applicable
• Heparinization vs Salinization of the Peripheral Venous CatheterRecruitingNCT05209841Not applicable
• Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal InfectionRecruitingNCT04861922Phase 3
• Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and RevascularizationRecruitingNCT04725201Phase 4
• Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.RecruitingNCT04561648Not applicable
• Heparin vs Placebo for Cardiac CatheterizationRecruitingNCT04374799Phase 3
• Anticoagulation-free VV ECMO for Acute Respiratory FailureRecruitingNCT04273607Phase 2/3
• Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase DeficiencyRecruitingNCT04227678Not applicable
• Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac SurgeryRecruitingNCT03302195Not applicable
• Nebulized Heparin for COVID19-associated Acute Respiratory FailureTerminatedNCT04842292Phase 2Results posted
• Enriched Heparin Anti COVID-19 TrialCompletedNCT04743011Phase 1/2Results posted
• Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTECompletedNCT04505774Phase 4Results posted
• Intranasal Heparin Tolerability StudyCompletedNCT04490239Early Phase 1Results posted
• Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients TrialCompletedNCT04409834Phase 4Results posted
• Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19CompletedNCT04367831Phase 4Results posted
• The Randomized OPTIMAL-ACT TrialCompletedNCT03772613Phase 2Results posted
• PREvention of VENous ThromboEmbolism Following Radical ProstatectomyTerminatedNCT03006562Phase 4Results posted
• Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain SyndromeTerminatedNCT02591199Phase 2Results posted
• Fatty Acid Oxidation Defects and Insulin SensitivityCompletedNCT02517307Not applicableResults posted
• Racial Differences in Vagal Control of Glucose HomeostasisCompletedNCT02365285Phase 1/2Results posted
• Feasibility Study of Unfractionated Heparin in Acute Chest SyndromeTerminatedNCT02098993Phase 2Results posted
• Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal SurgeryCompletedNCT01976988Phase 3Results posted
• Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After SurgeryCompletedNCT01608906Not applicableResults posted
• Effect of Increased Free Fatty Acids on Leptin FunctionCompletedNCT01520454Not applicableResults posted
• How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary InterventionCompletedNCT01519518Phase 4Results posted
• A Comparison of Dilute Versus Concentrated Heparin for CRRT AnticoagulationTerminatedNCT01318811Phase 4Results posted
• Study to Characterize the Effect of Heparin on Palifermin ActivityCompletedNCT01163097Phase 1Results posted
• Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart RhythmCompletedNCT00911300Phase 2Results posted
• Heparin and the Reduction of Thrombosis (HART) TrialCompletedNCT00779558Not applicableResults posted
• HEROIC (Heparin Requirement in Counterpulsation)TerminatedNCT00445211Phase 2Results posted
• Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial InfarctionCompletedNCT00433966Phase 3Results posted
• Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU PatientsCompletedNCT07366372Not applicable
• Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudyCompletedNCT06365398Phase 4
• Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation InjuryCompletedNCT05886998Phase 3
• Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous AdministrationStatus unknownNCT05788913Phase 1
• Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous AdministrationStatus unknownNCT05788900Phase 1
• Heparin-free Extracorporeal Membrane Oxygenation Support During Clinical Lung TransplantationStatus unknownNCT05697692Phase 4
• Early Administration of Heparin At FMC for PPCI of STEMI PatientsCompletedNCT05329155Not applicable
• Nebulised Heparin in Patients With COVID-19 PneumoniaStatus unknownNCT05255848Phase 2/3
• Pretreatment With Unfractionated Heparin for ST Elevation Myocardial InfarctionCompletedNCT05247424Phase 4
• Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and ChildrenCompletedNCT05204550Phase 2/3
• Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)WithdrawnNCT05184101Phase 2/3
• A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.CompletedNCT05178550Early Phase 1
• UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit.CompletedNCT05148377Phase 3
• Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis CathetersCompletedNCT04772209Not applicable
• Continuous Heparin Infusion to Prevent Catheter-related ThrombosisCompletedNCT04767113Not applicable
• Nebulized Heparin for the Treatment of COVID-19CompletedNCT04723563Phase 4
• Inhaled Heparin for Hospitalised COVID-19 PatientsCompletedNCT04635241Phase 2/3
• Nebulised Heparin in Patients With Severe COVID-19CompletedNCT04545541Phase 2/3
• Reduced Anticoagulation Targets in ECLS (RATE)CompletedNCT04536272Phase 3
• Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19Status unknownNCT04530578Phase 4
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 InfectionStatus unknownNCT04528888Phase 3
• Nebulised Heparin to Reduce COVID-19 Induced Acute Lung InjuryCompletedNCT04511923Phase 1/2
• CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19CompletedNCT04487990Not applicable
• Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 PneumoniaWithdrawnNCT04485429Phase 3
• Nebulized Heparin for the Treatment of COVID-19 Induced Lung InjuryTerminatedNCT04397510Phase 4
• Anticoagulation Therapy After Splenectomy in Cirrhosis PatientCompletedNCT04397289Phase 1/2
• Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)CompletedNCT04372589Phase 2/3
• Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot AnalyzerCompletedNCT04355273Not applicable
• Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic PatientsCompletedNCT04313790Phase 2
• Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) MembraneStatus unknownNCT04139525Not applicable
• Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior CirculationStatus unknownNCT04121611Not applicable
• Comparison of Two Dosages of Heparin Before Extracorporeal CirculationCompletedNCT03752437Phase 4
• Bivalirudin vs Heparin in ECMO PatientsWithdrawnNCT03707418Phase 1
• Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCICompletedNCT03664180Phase 4
• Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign HysterectomyStatus unknownNCT03633994Phase 2
• A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular DysfunctionActive, not recruitingNCT03537586Not applicable
• Acute Mesenteric Venous Thrombosis.. in Assiut University Hospital Management ControversiesStatus unknownNCT03483207Not applicable
• Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDSCompletedNCT03465085Phase 3
• Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin MonitoringStatus unknownNCT03426982Phase 4
• Heparin Anticoagulation in Septic ShockTerminatedNCT03378466Phase 2
• Coronary Arteriogenetic Heparinized ExerciseCompletedNCT03350737Not applicable
• Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPDCompletedNCT03333395Phase 4
• Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2Status unknownNCT03306836Not applicable
• The Effect of Heparinization Due to LBWStatus unknownNCT03113708Phase 4
• Timing of VTE Prophylaxis in TBIWithdrawnNCT03081169Phase 4
• The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy LossStatus unknownNCT02990403Phase 4
• Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With ThrombophillaStatus unknownNCT02986594Phase 4
• Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic SurgeryStatus unknownNCT02940444Phase 1/2
• Randomized Anticoagulation Trial in Opcab (RATIO)Status unknownNCT02812355Phase 4
• Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill PatientsWithdrawnNCT02707263Not applicable
• Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion SetCompletedNCT02687256Phase 1
• Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)CompletedNCT02674906Not applicable
• Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular CoagulationStatus unknownNCT02654561Phase 3
• Predictive Factors of Intestinal Infraction in Acute Mesenteric IschemiaCompletedNCT02645240Phase 4
• Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in ChildrenStatus unknownNCT02515201Phase 4
• Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing HeparinSuspendedNCT02501434Phase 2
• Heparin for the Treatment of Burn Wound PainStatus unknownNCT02497326Not applicable
• Effects of Heparin on Arteriovenous Fistula PatencyCompletedNCT02493504Phase 4
• Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following HeparinCompletedNCT02206087Phase 1/2
• Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)CompletedNCT02181985Phase 3

← Heparin overview